RxDoctor Payments Data

Michael Grossman

Reproductive Endocrinology · Latham, NYNPI 1467455816

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 203 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Organon at 37.7% of the total. Reporting peaked in 2022 at $784 and has fallen 61.1% since, to $305 in 2025.

$3,594in general payments, 2019–2025

Across 203 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$1K
  • EMD Serono, Inc.$483
  • Merck$479
  • AbbVie$415
  • Ferring Pharmaceuticals Inc.$340
  • Coopersurgical, Inc.$146
  • plus $377 from 10 others

What the payments were for

  • Food & beverage$3,57499%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,594 in reported general payments places this provider in the 85th percentile of 176 reproductive endocrinology providers in New York.

See all reproductive endocrinology providers in New York

Other reproductive endocrinology in Latham

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →